National blood cancer charity Cure Leukaemia has unveiled a vivid rebrand and website, spearheaded by Manchester-based brand and digital agency Ultimate.
The new identity, launched to coincide with Blood Cancer Awareness Month, reflects the charity’s determination to beat leukaemia for good.
Founded in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley, Cure Leukaemia has grown into a national charity funding clinical roles at blood cancer centres across the UK.
Its work helps patients, both adults and children, access pioneering trials for new treatments. The charity counts broadcaster Gary Lineker among its high-profile supporters.
With a new blood cancer diagnosis every 27 seconds worldwide, the charity is driven by its mission statement: “We will stop at nothing.”
READ MORE: Data compliance expert led by AIM’s former youngest CEO makes agency appointment
Ultimate’s rebrand captures Cure Leukaemia’s spirit of tenacity and hope. The redesigned logo ensures ‘cure’ stands tall above ‘leukaemia’, supported by vibrant colours, robust typography and energetic graphics.
Real patient photography, alongside imagery from Cure Leukaemia’s thriving fundraising community, ensures the brand is rooted in its real-life impact.
Alongside the visual update, Ultimate developed a modern, accessible, and conversion-focused website tailored to three key audiences: patients, fundraisers, and donors. Key improvements include:
- Streamlined donation journeys with progress bars and tailored messaging
- Integration with Cure Leukaemia’s CRM to strengthen supporter relationships
- Enhanced visibility for fundraising events and campaigns.
Ultimate founder Matt Townsend first joined forces with Cure Leukaemia in 2021, riding the full Tour de France as part of the charity’s Tour 21 challenge and helping to raise over £1 million.
Since then, Ultimate has supported the charity in its mission to accelerate research and access to treatments through ground-breaking initiatives such as the ATICUS Network.
“Cure Leukaemia’s determination to stop at nothing is contagious,” said Townsend. “We’re proud to play our part in their journey.”
Cure Leukaemia is expanding its reach through initiatives – such as September’s Move The Nations campaign and the launch of corporate network Club 10 – while continuing to fund pioneering roles that bring world-class trials to patients across the UK.
Chief Executive of Cure Leukaemia, James McLaughlin, added: “This rebrand is about powering our mission forward. With the support of our community, we will cure leukaemia. Our bold new face positions us even closer to that goal.”
